Semaglutide is a GLP-1 receptor agonist that affects appetite and glucose regulation. The proposed product, expected benefit and potential risks require individual assessment. At Altera Wellness in Temple Terrace, serving Tampa, every semaglutide protocol is physician-designed and individually titrated from the first visit.
Semaglutide Tampa & Temple Terrace | Altera Wellness
Semaglutide
How It Works:
- GLP-1 receptor activation: Semaglutide binds GLP-1 receptors in the hypothalamus and brainstem, directly modulating satiety signals — slowing gastric emptying and reducing the neurological drive to eat between meals.
- Glucose regulation: Semaglutide affects insulin and glucagon in a glucose-dependent way. Diabetes treatment and low-blood-sugar risk need individual review.
- Body composition: Weight loss can include lean tissue as well as fat. Nutrition, appropriate resistance activity and monitoring matter.
Safety and eligibility:
- The approved product is contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).
- Severe gastroparesis is a reason the approved product label advises against use. A history of pancreatitis or other gastrointestinal disease needs individual review.
- Weight-loss treatment is not appropriate during pregnancy. Discuss planned pregnancy and breastfeeding with the prescriber; recommendations depend on the exact product.
- A serious allergy to the medicine or its ingredients is another contraindication. This is not an exhaustive safety review. Eligibility is determined during your physician consultation at Altera — Dr. Hasan reviews your full history before any protocol is initiated.
What To Expect
Understanding expected outcomes
Clinical evidence for approved medicines applies to the studied product and population. It does not establish results for a compounded preparation. Compounded semaglutide is not FDA-approved; discuss the exact proposed product, uncertainties and alternatives.
Appetite and tolerability
Appetite changes and tolerability vary. Discuss your response and any difficulty eating adequately with the treating clinician.
Monitoring beyond the scale
Clinical follow-up may assess weight, symptoms and relevant health measures. Approved-drug trial findings should not be treated as evidence for a compounded formulation.
Common adverse reactions include nausea, vomiting, diarrhea and constipation. Symptoms can sometimes be severe or persistent; contact the prescriber rather than assuming they will resolve.
Learn More
Questions about your treatment
Is semaglutide the same as Wegovy or Ozempic?
Semaglutide is an active ingredient used in different prescription products. Product names, approved uses and formulations matter. A compounded semaglutide product is not an FDA-approved generic or an interchangeable version of a branded medicine. Ask for the exact product and patient information.
What medical history matters before semaglutide?
The Wegovy label excludes a personal or family history of medullary thyroid carcinoma, MEN 2, or a serious allergic reaction to its ingredients. Report pancreas, gallbladder, kidney, stomach-emptying and eye problems. Severe gastroparesis is a reason the label advises against use.
Which semaglutide symptoms need prompt medical attention?
Seek urgent medical advice for severe or persistent abdominal pain, repeated vomiting or inability to keep fluids down. Breathing difficulty or swelling of the face or throat requires emergency care. Report new vision changes promptly. Do not assume every symptom is a routine adjustment.
What if I am planning pregnancy while using semaglutide?
Weight-loss treatment is not appropriate during pregnancy. The Wegovy label advises stopping at least two months before a planned pregnancy. Discuss pregnancy plans, possible pregnancy and breastfeeding with your prescriber; advice depends on the exact product and circumstances.
Will semaglutide preserve all my muscle while I lose weight?
No medicine can promise that. Weight loss can include lean tissue as well as fat. Adequate nutrition and resistance activity appropriate to your health, together with monitoring of strength and function, matter during treatment. Ask for help if reduced appetite makes eating adequately difficult.
What if my semaglutide instructions or syringe markings are unclear?
Contact the prescriber or dispensing pharmacist before injecting. FDA has reported serious errors with compounded semaglutide, including confusion about concentration and measurement. Do not calculate a replacement dose from another person’s instructions or assume different vials use the same concentration.
